Humana Inc. $HUM Shares Sold by VeriStar Capital Management LP

Key Points

• VeriStar Capital Management LP has reduced its holdings in Humana Inc. by 45.3%, selling 11,443 shares and now owns 13,796 shares valued at $3,650,000.
• Despite the recent share sell-off, institutional investors have shown increasing interest, with Vanguard raising its stake in Humana by 8.9% and GAMMA Investing LLC increasing its position by an extraordinary 40,881.1%.
• Humana's stock has an average rating of "Hold" from analysts and a consensus price target of $283.29, with shares currently trading around $303.90.

VeriStar Capital Management LP lessened its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 45.3% in the first quarter, according to its most recent filing with the SEC. The firm owned 13,796 shares of the insurance provider's stock after selling 11,443 shares during the period. Humana accounts for 6.7% of VeriStar Capital Management LP's portfolio, making the stock its 9th largest position. VeriStar Capital Management LP's holdings in Humana were worth $3,650,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Cary Street Partners Investment Advisory LLC boosted its holdings in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after buying an additional 46 shares during the period. Applied Finance Capital Management LLC lifted its position in shares of Humana by 1.7% in the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock valued at $779,000 after buying an additional 48 shares during the last quarter. Achmea Investment Management B.V. lifted its position in shares of Humana by 0.5% in the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock valued at $2,746,000 after buying an additional 49 shares during the last quarter. Beech Hill Advisors Inc. lifted its holdings in Humana by 6.1% during the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after purchasing an additional 50 shares during the last quarter. Finally, Townsquare Capital LLC lifted its stake in shares of Humana by 2.8% during the 1st quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock worth $597,000 after buying an additional 61 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of several research reports. Bank of America lifted their price target on Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a report on Tuesday. Truist Financial dropped their price objective on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Robert W. Baird dropped their price objective on shares of Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Wells Fargo & Company dropped their price target on shares of Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a research report on Thursday, August 14th. Finally, Wall Street Zen downgraded shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Seven investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $289.24.

Humana Price Performance

HUM stock traded down $4.07 during midday trading on Friday, reaching $307.94. 1,504,536 shares of the stock were exchanged, compared to its average volume of 1,704,650. The stock has a market capitalization of $37.04 billion, a PE ratio of 23.63, a P/E/G ratio of 1.83 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The company has a fifty day moving average price of $260.14 and a 200 day moving average price of $256.12. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $369.17.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The business had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same quarter in the prior year, the business earned $6.96 earnings per share. The firm's quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.